Inflexion exits European LifeCare Group

The mid-market private equity firm, Inflexion, has sold its investment in European LifeCare Group (ELCG) to a Europe-based private equity firm. During the partnership, ELCG has completed four acquisitions, expanded into new markets, and nearly tripled its revenue.

ELCG is one of the largest private providers of vaccination programs in Europe with 84 specialist vaccination clinics across Denmark, the UK, the Netherlands, and Sweden. The company offers a comprehensive range of services, from travel and routine health vaccinations to large-scale immunisation programmes. For more than two decades, ELCG has been a trusted partner in delivering national vaccination programmes for both the Danish health authorities and the UK’s NHS.

During Inflexion’s ownership, ELCG completed four strategic acquisitions, expanded into the Benelux and Swedish markets, and nearly tripled its revenue. Over the same period, the number of clinics grew by 65%, headcount increased sixfold, and the total number of vaccinations delivered increased to more than three million annually.

Mazanti Transactions has advised sell-side on all aspects of the transaction in collaboration with the international law firm, Trowers & Hamlins. Mazanti Transactions has also advised ELCG’s management team in connection with their re-investment.